Reversed hydroxamate-bearing thermolysin inhibitors mimic a high-energy intermediate along the enzyme-catalyzed proteolytic reaction pathway

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 19, 2003, Pages 3161-3166

  Park, Jung Dae ^a   Kim, Dong H ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; ENZYME INHIBITOR; HYDROXAMIC ACID; THERMOLYSIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CORRELATION ANALYSIS; GEOMETRY; IONIZATION; KINETICS; PROTEIN DEGRADATION;

EID: 0042833023     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00720-0     Document Type: Article

References (27)

1. Lipscomb N.W., Sträter N. Chem. Rev. 96:1996;2375.
2. Beynon, R. J.; Beaumont, A. In Handbook of Proteolytic Enzymes; Barrett, A. J., Rawlings, N. D., Woessner, J. F. Eds: Academic: New York, 1998; p 1037.
3. Zuman M.A., Oparil S., Calhoun D.A. Nat. Rev. Drug Discov. 1:2002;621.
4. Wittaker M., Floyd D.D., Brown P., Gearing A.J.H. Chem. Rev. 99:1999;2735.
5. Powers, J. C.; Harper, J. W. Inhibitors of Metalloproteases. In Protease Inhibitors; Barrett, A. J., Salvesan, G., Eds.; Elsevier Science: Amsterdam, 1986; p 219.
6. (a) Kraut J. Science. 242:1988;533
7. (b) Cannon W.R., Sergleton S.F., Benkovic S.J. Nat. Struct. Biol. 3:1996;821.
8. (a) Wolfenden R. Acc. Chem. Res. 5:1972;10
9. (b) Lienhard G.E. Science. 180:1973;149
10. (c) Wolfenden, R. Transition State Affinity and the Design of Enzyme Inhibitors. In Enzyme Mechansims; Page, M. I., Williams, A., Eds.; Royal Chemical Society: London, 1987; p 97.
11. Bartlett P.A., Marlowe C.K. Biochemistry. 22:1983;4618.
12. Mader M.M., Bartlett P.A. Chem. Rev. 97:1997;1281.
13. Hanson J.E., Kaplan A.P., Bartlett P.A. Biochemistry. 28:1989;6294.
14. Jin Y., Kim D.H. Bioorg. Med. Chem. Lett. 8:1998;3515.
15. 6, 300 MHz) δ 22.6, 23.5, 26.2, 40.0, 51.2, 52.5, 75.6, 129.4, 129.7, 129.8, 135.1, 174.9.
16. Feder J., Broughham L.R., Wildi B.S. Biochemistry. 13:1974;1186.
17. Matthews B.W. Acc. Chem. Res. 21:1988;333.
18. Izquierdo M.C., Stein R.L. J. Am. Chem. Soc. 112:1990;6054.
19. Beaumont A., O'Donohue M.J., Peredes N., Rousselet N., Assicot M., Bohuon C., Fourié-Zaluske M.-C., Roques B. J. Biol. Chem. 270:1995;16803.
20. Hangauer D.G., Monzingo A.F., Matthews B.W. Biochemistry. 23:1984;5730.
21. (a) Antonczak S., Monard G., Ruiz-Lopez M.F., Revail J.-L. J. Am. Chem. Soc. 120:1998;8825
22. (b) Antonczak S., Monard G., Ruiz-Lopez M.F., Revail J.-L. J. Mol. Model. 6:2000;527
23. (c) Pelmenschikov V., Blomberg M.R.A., Siegbahn P.E.M. J. Biol. Inorg. Chem. 7:2002;284.
24. Kim S.-J., Kim D.H., Park J.D., Woo J.-R., Jin Y., Ryu S.E. Bioorg. Med. Chem. 11:2003;2421.
25. (a) The deprotonation may most likely be resulted as a consequence of the high Lewis acidity of the zinc ion: Izquierdo-Martin M., Stein R.L. J. Am. Chem. Soc. 114:1992;325 (b) Cross J.B., Duca J.S., Kaminski J.J., Madison V.S. J. Am. Chem. Soc. 124:2002;11004.
26. (a) The deprotonation may most likely be resulted as a consequence of the high Lewis acidity of the zinc ion: Izquierdo-Martin M., Stein R.L. J. Am. Chem. Soc. 114:1992;325 (b) Cross J.B., Duca J.S., Kaminski J.J., Madison V.S. J. Am. Chem. Soc. 124:2002;11004.
27. Morihara K., Tsuzuki H. Eur. J. Biochem. 15:1970;374.